Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-κB pathway in the macrophage

Peptides

Volumn 30, Issue 12, 2009, Pages 2388-2398

  de Mejia, Elvira Gonzalez ^a   Dia, Vermont P ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Inflammation; Lunasin; Lunasin like peptides; NF B; Soybean

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LUNASIN; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN P50; SOYBEAN PROTEIN; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; HOST RESISTANCE; INHIBITION KINETICS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN TRANSPORT; SOYBEAN; TRANSACTIVATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE PROTEINS; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDES; SIGNAL TRANSDUCTION; SOYBEAN PROTEINS;

GLYCINE MAX; MAMMALIA;

EID: 70449642672     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.08.005     Document Type: Article

References (43)

1. Anuhadra C.D., Kanno S., and Hirano S. RGD peptide-induced apoptosis in human leukemia HL-60 cells required caspase-3 activation. Cell Biol Toxic 16 (2000) 275-283
2. Chung H.T., Choi B.M., Kwon Y.G., and Kim Y.M. Interactive relations between nitric oxide (NO) and carbon monoxide (CO): heme-oxygenase-1/CO pathway is a key modulator in NO mediated anti-apoptosis and anti-inflammation. Methods Enzymol 441 (2008) 329-338
3. Dannenberg A.J., Altorki N.K., Boyle J.O., Dang C., Howe L.R., Weksler B.B., et al. Cyclooxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2 (2001) 544-555
4. de Mejia E.G., Vasconez M., de Lumen B.O., and Nelson R. Lunasin concentrations in different soybean genotypes, commercial soy protein and isoflavone products. J Agric Food Chem 52 (2004) 5882-5887
5. Dia V.P., Torres S., de Lumen B.O., Erdman J.W., and Gonzalez de Mejia E. Presence of lunasin in plasma of young men after consumption of soy protein. J Agric Food Chem 57 (2009) 1260-1266
6. Dia V.P., Wang W., Oh V.L., de Lumen B.O., and Gonzalez de Mejia E. Isolation, purification and characterization of lunasin from defatted soybean flour and in vitro evaluation of its anti-inflammatory activity. Food Chem 114 (2009) 108-115
7. Galvez A.F., Chen N., Macasieb J., and de Lumen B.O. Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res 61 (2001) 7473-7478
8. Gilmore T.D. Introduction to NF-kappa B: plays, pathways, perspectives. Oncogene 25 (2006) 6680-6684
9. Gonzalez de Mejia E, Wang W, Dia VP. Lunasin with an arginine-glycine-aspartic acid motif causes apotosis to L1210 leukemia cells by activation of caspase-3. Mol Nutr Food Res, in press, mnrf.200900073.
10. Hernandez-Ledesma B., Hsieh C., and de Lumen B.O. Lunasin, a novel seed peptide for cancer prevention. Peptides 30 (2009) 426-430
11. 2O labeling: a sensitive marker of epidermal proliferation state. J Invest Dermatol 123 (2004) 530-536
12. Ianaro A., Tersigni M., Belardo G., Di Martino S., Napolitano M., Plamieri G., et al. NEMO-binding domain peptide inhibits proliferation of human melanoma cells. Cancer Lett 274 (2009) 331-336
13. Jackson L., and Evers B.M. Chronic inflammation and pathogenesis of gastrointestinal and pancreatic cancers. Cancer Treat Res 130 (2006) 39-65
14. Jeong H.J., Jeong J.B., Kim D.S., Park J.H., Lee J.B., Kweon D.H., et al. The cancer preventive peptide lunasin from wheat inhibits core histone acetylation. Cancer Lett 255 (2007) 42-48
15. Jeong H.J., Lam Y., and de Lumen B.O. Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells. J Agric Food Chem 50 (2002) 5903-5908
16. Jeong J.B., Jeong H.J., Park J.H., Lee S.H., Lee J.R., Lee H.K., et al. Cancer preventive-peptide lunasin from Solanum nigrum L. inhibits acetylation of core histones H3 and H4 and phosphorylation of retinoblastoma protein (Rb). J Agric Food Chem 55 (2007) 10707-10713
17. Jeong J.H., Park J.H., Lam Y., and de Lumen B.O. Characterization of lunasin isolated from soybean. J Agric Food Chem 51 (2003) 7901-7906
18. Jobin C., and Balfour Sartor R. The IκB/NF-κB system: a key determinant of mucosal inflammation and protection. Am J Physiol Cell Physiol 278 (2000) C451-C462
19. Johnston G.R., and Webster N.R. Cytokines and the immunomodulatory function of the vagus nerve. Brit J Anaes 102 (2009) 453-462
20. Karin M., and Greten F.R. NF-kappa B: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5 (2005) 749-759
21. Kawai T., and Akira S. Signaling to NF-κB by Toll-like receptors. TRENDS Mol Med 13 (2007) 460-469
22. Kim J.H., Bachman R.A., and Chen J. Interleukin-6 and insulin resistance. Vit Horm Insulin IGFS 80 (2009) 613-633
23. Kim J.Y., Kim T.H., and Kim S.S. Anti-inflammatory effect of a human prothrombin fragment-2-derived peptide, NSA9, in EOC microglia. Biochem Biophys Res Commun 368 (2008) 779-785
24. Lee M.M., Gomez S.L., Chang J.S., Wey M., Wang R.T., and Hsing A.W. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev 12 (2003) 665-668
25. Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 65 (2007) S140-S146
26. Lin A., and Karin M. NF-kappa B regulation in the immune system. Nat Rev Immunol 2 (2002) 725-734
27. Lu H., Shi J.X., Zhang D.M., Wang H.D., Hang C.H., Chen H.L., et al. Inhibition of hemolysate-induced iNOS and COX-2 expression by genistein through suppression of NF-κB activation in primary astrocytes. J Neurol Sci 278 (2009) 91-95
28. Matsuki K., Sasho T., Nakagawa K., Tahara M., Sugioka K., Ochiai N., et al. RGD peptide-induced cell death of chondrocytes and synovial cells. J Orthop Sci 13 (2008) 524-532
29. McCrathy K.D., and de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85 (1980) 890-902
30. Moon C., Ran Han J., Park H.J., Hah J.S., and Kang J.L. Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Resp Res 10 (2009) 18-32
31. Mora A.L., LaVOY J., McKean M., Stecenko A., Brigham K.L., and Parker R. Prevention of NF-κB activation in vivo by a cell-permeable inhibitor peptide. Am J Physiol Lung Cell Mol Physiol 289 (2005) L536-L544
32. Mota M., Garvagu S., Popa S., Schiopu S., Panduru N.M., and Mota E. Soya - the medicine food product. Rom J Int Med 45 (2007) 113-121
33. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 6 (1992) 3051-3064
34. Ogawara K., Kuldo J.M., Oosterhuis K., Kroesen B.J., Rots M.G., Trautwein C., et al. Functional inhibition of NF-κB signal transduction in αvβ3 integrin expressing endothelial cells by using RGD-PEG-modified adenovirus with a mutant IκB gene. Arthr Res 8 (2006) R32-R41
35. Raj D.S.C. Role of interleukin-6 in the anemia of chronic disease. Semin Arthritis Rheum 38 (2009) 382-388
36. Rijkers K., Majoie H.J., Hoogland G., Kenis G., De Maets M., and Vles J.S. The role of IL-1 in seizures and epilepsy: a critical review. Exp Neurol 216 (2009) 258-271
37. Ruoslahti E. RGD and other recognition sequences for integrins. Ann Rev Cell Dev Biol 12 (1996) 697-715
38. Sarkar F., and Li Y. Cell signaling pathways altered by natural chemopreventive agents. Mut Res 555 (2004) 53-64
39. Schottenfeld D., and Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56 (2006) 69-83
40. Silva-Sanchez C., Barba de la Rosa A.P., Leon-Galvan M.F., de Lumen B.O., de Leon Rodriguez A., and Gonzalez de Mejia E. Bioactive peptides in amaranth (Amaranthus hypochondriacus) seed. J Agric Food Chem 56 (2008) 1233-1240
41. Storz P., and Toker A. NF-kappa B signalling-an alternative pathway for oxidative stress responses. Cell Cycle 2 (2003) 9-10
42. Xu G.L., Liu F., Ao G.Z., He S.Y., Ju M., Zhao Y., et al. Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa, a novel dual COX/5-LOX inhibitor. Eur J Pharmacol 611 (2009) 100-106
43. Yamamoto S., Sobue T., Kobayashi M., Sasaki S., and Tsugane S. Soy, isoflavones and breast cancer risk in Japan. J Natl Cancer Inst 95 (2003) 906-913